Puma Biotech (PBYI) Tops Q1 EPS by 24c

Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of ($0.65), $0.24 better than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks